All-cause mortality among patients treated with repurposed antivirals and antibiotics for COVID-19 in Mexico City: A real-world observational study.

EXCLI J · 2021 · PMC7898041 · PMID 33628159

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Oseltamivir was associated with increased risk of death in both early (HR=3.00, 95 % CI: 2.14-4.20) and late (HR=2.99, 95 % CI: 1.83-4.89) groups, as well as late use of lopinavir-ritonavir (HR=9.9, 95 % CI: 2.49-39.83); all other early/late antivirals did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.